FDA Adverse Event Malfunction Summary report: N

EDWARDS OXIMETRY CENTRAL VENOUS CATHETER

MDR report key: 17965952 · Received October 19, 2023

Report

Report Number
2015691-2023-16909
Event Type
Malfunction
Date Received
October 19, 2023
Date of Event
September 28, 2023
Report Date
July 18, 2024
Manufacturer
EDWARDS LIFESCIENCES, PR
Product Code
DQE
UDI-DI
00690103197433
PMA / PMN Number
K053609
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ONE TRIPLE LUMEN OXIMETRY CATHETER WAS RETURNED FOR EVALUATION. SUTURE LOOP AND BOX CLAMP WERE ATTACHED ON CATHETER BODY AT 13 TO 15CM MARKER AREA. NON EDWARDS INJECTION PORTS WERE ATTACHED AT LUMEN HUBS. THE CUSTOMERS REPORT OF LEAKAGE WAS OBSERVED FROM THE PROXIMAL EXTENSION TUBE WAS CONFIRMED. AS RECEIVED, THE PROXIMAL EXTENSION TUBE WAS FOUND CUT, APPROXIMATELY 1MM IN SIZE, AT APPROXIMATELY 97MM PROXIMAL FROM BACKFORM. LEAKAGE WAS OBSERVED FROM THE CUT ON PROXIMAL EXTENSION TUBE. BOTH THE DISTAL AND MEDIAL LUMENS WERE FOUND TO BE PATENT WITHOUT ANY LEAKAGE OR OCCLUSION. AN ENGINEERING EVALUATION WAS INITIATED TO ASSESS FOR ANY MANUFACTURING RELATED PROCESSES WHICH COULD BE CORRELATED TO THE COMPLAINT. BASED ON THE AVAILABLE INFORMATION THERE IS NO EVIDENCE THAT SUPPORTS OR CONFIRMS THE FAILURE MODE IS ASSOCIATED TO A MANUFACTURING/DESIGN DEFECT. COMPLAINT HISTORIES FOR ALL REPORTED EVENTS ARE REVIEWED AGAINST TRENDING CONTROL LIMITS ON A MONTHLY BASIS AND ANY EXCURSIONS ABOVE THE CONTROL LIMITS ARE ASSESSED AND DOCUMENTED AS A PART OF THE MONTHLY REVIEW. CORRECTION: UPDATES TO THE H6 CODES ARE AS FOLLOWS: TYPE OF INVESTIGATION WAS CHANGED TO TESTING OF ACTUAL SUSPECTED DEVICE. INVESTIGATION FINDINGS WAS CHANGED TO LEAKAGE SEAL. INVESTIGATION CONCLUSIONS WAS CHANGED TO CAUSE NOT ESTABLISHED.

Additional Manufacturer Narrative · 0

UDI RELATED DATA QUALITY UPDATES ONLY. THE LOT NUMBER FOR THIS DEVICE WAS NOT PROVIDED AND IS UNKNOWN, THEREFORE, THE FULL UDI NUMBER IS NOT AVAILABLE. THE PRIMARY DI NUMBER IS: (B)(4). THE FOLLOWING ARE ADDITIONAL PRODUCT CODES FOR THIS DEVICE: DRE; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION. DXG; COMPUTER, DIAGNOSTIC, PRE-PROGRAMMED, SINGLE-FUNCTION. THE FOLLOWING IS CORRECTED DATA, AS THE ORIGINAL IDENTIFICATION INFORMATION SENT IN THE INITIAL REPORT DID NOT MATCH THE DATA SUBMITTED TO THE GLOBAL UNIQUE DEVICE IDENTIFICATION DATABASE (GUDID): D1 BRAND NAME: EDWARDS OXIMETRY CENTRAL VENOUS CATHETER.

Additional Manufacturer Narrative · 0

THE DEVICE IS ANTICIPATED TO BE RETURNED FOR EVALUATION BUT HAS NOT YET BEEN RECEIVED. A SUPPLEMENTAL WILL BE SENT WITH THE EVALUATION RESULTS. A DEVICE HISTORY RECORD REVIEW WAS UNABLE TO BE COMPLETED AS THE LOT NUMBER IS UNKNOWN. H3 OTHER TEXT: DEVICE NOT RETURNED.

Description of Event or Problem · 0

IT WAS REPORTED THAT WHILE USING THIS X3820SJD DEVICE, BLOOD MIXED WITH MEDICATION LEAKAGE WAS OBSERVED FROM THE PROXIMAL EXTENSION TUBE AFTER A MITRAL VALVE REPLACEMENT (MVR) PROCEDURE. THE SYSTOLIC BLOOD PRESSURE TEMPORARILY DROPPED FROM 100MMHG TO 40MMHG DUE TO MEDICATION LEAKAGE. HOWEVER, THE PATIENT OUTCOME RECOVERED. THE FOLLOWING ADDITIONAL TREATMENTS WERE PERFORMED DUE TO BLOOD AND MEDICATION LEAKAGE: TREATMENT TO INCREASE BLOOD PRESSURE (DETAILS UNKNOWN) AND STARTING AN IV LINE WITH PRE-EXISTING ACCESS CATHETER FOR HEMODIALYSIS. THE CENTRAL VENOUS (CV) CATHETER WAS REMOVED WITHOUT A REPLACEMENT. LEAKED MEDICATIONS WERE CATECHOLAMINE, NORADRENALINE, LANDIOLOL HYDROCHLORIDE AND NICORANDIL DILUTED WITH SALINE AND GLUCOSE. THE AMOUNT OF BLOOD LEAKAGE IS UNKNOWN. THERE WAS NO EXTENSION OF HOSPITALIZATION WAS REQUIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1750415 EDWARDS OXIMETRY CENTRAL VENOUS CATHETER CATHETER, OXIMETER, FIBER-OPTIC DQE EDWARDS LIFESCIENCES, PR X3820SJD 00690103197433

Patients

Seq Age Sex Outcome Treatment
1 61 YR Male